Vaccine Adjuvants Market Overview, Growth, Trends, Analysis, Research Report (2021-2031)

Vaccine Adjuvants Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Adjuvant Class (Mineral Salt Adjuvant, Emulsion Adjuvant, Liposome Adjuvant, and Others), Type (Human Vaccine Adjuvant and Veterinary Vaccine Adjuvant), and Geography

  • Report Code : TIPRE00004430
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

The vaccine adjuvants market size is projected to reach US$ 7.96 billion by 2031 from US$ 2.79 billion in 2023. The market is expected to register a CAGR of 14.0% during 2023–2031. Technological advancements is likely to remain key trends in the market.

Vaccine Adjuvants Market Analysis

In 2020, NIAID established Vaccine Adjuvant Compendium (VAC) for the collaboration between broader scientific community and NIAID-supported vaccine adjuvant researchers. This network-based tool displays adjuvant characteristics to assist vaccine makers to identify suitable adjuvants for target disease.  Also, support various government authorities to foster vaccine adjuvant R&D, top manufacturers collaborations, and product launches through such business strategies are likely to provide profitable opportunities for the growth of the vaccine adjuvants market during the forecast period.

Vaccine Adjuvants Market Overview

Vaccine Adjuvant Technology encompasses nanotechnology, and its production includes supercritical, critical, or near-critical fluids with or without polar cosolvents such as ethanol [referred to as superfluids (SFS)]. Biodegradable biopolymers are dissolved in SFS and mixed with subunit vaccines in an aqueous solution or as a slurry of nanoparticles. Therefore, such new vaccine adjuvant technologies are being developed to make biodegradable polymer nanospheres (PNS) through novel processes, which allows vaccine manufacturers to rule out the use of organic solvents.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Vaccine Adjuvants Market: Strategic Insights

Vaccine Adjuvants Market

  • CAGR (2023 - 2031)
    14.0%
  • Market Size 2023
    US$ 2.79 Billion
  • Market Size 2031
    US$ 7.96 Billion

Market Dynamics

GROWTH DRIVERS
  • Advantages of Vaccine Adjuvants to Favor Market
FUTURE TRENDS
  • Collaborative Efforts for Vaccine Adjuvants
OPPORTUNITIES
  • Product Launches and Developments in Adjuvant Studies

Key Players

  • SPI Pharma Inc
  • GSK Plc
  • CSL Ltd
  • Seppic SA
  • Hawaii Biotech Inc.
  • Dynavax Technologies Corp
  • InvivoGen SAS
  • Croda International Plc
  • Novavax Inc
  • Phibro Animal Health Corp

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Adjuvant Class
  • Mineral Salt Adjuvant
  • Emulsion Adjuvant
  • Liposome Adjuvant
Type
  • Human Vaccine Adjuvant
  • Veterinary Vaccine Adjuvant
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Vaccine Adjuvants Market Drivers and Opportunities

Advantages of Vaccine Adjuvants to Favor Market

In recent years, adjuvant vaccines have been developed to enhance humoral and cell-mediated immune response after vaccination. By adding adjuvant components, vaccine efficacy is improved. The primary mechanisms of actions of the newer adjuvants involve enhancement of the innate immune system and lead to improved humoral and cell-mediated immunity against infections in populations.

Product Launches and Developments in Adjuvant Studies

Over past decades, non-biogenic adjuvants, biogenic adjuvants, and their multi-type of composite adjuvant materials studies are increasing, aiming at providing a theoretical basis for developing feasible and effective adjuvants for oral vaccines. With increasing studies related to vaccine adjuvants, strategic initiative are also happening in the market. For instance, In August 2023, Bimervax, the COVID-19 vaccine developed by the HIPRA Human Health, received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA). Bimervax is part of the SARS-CoV-2 virus spike protein combined with an adjuvant acting as an additional ingredient designed to trigger a strong immune response. It can also be administered as a booster shot in the upper arm, particularly for those aged 16 years and over. Such approvals for vaccine adjuvants is likely to favor the market growth from 2020 to 2030.

Vaccine Adjuvants Market Report Segmentation Analysis

Key segments that contributed to the derivation of the vaccine adjuvants market analysis are adjuvant class and type.

  • Based on adjuvant class, the vaccine adjuvants market is divided into mineral salt adjuvant, emulsion adjuvant, liposome adjuvant, and others. The mineral salt adjuvant segment held a larger market share in 2023.
  • By type, the market is bifurcated into human vaccine adjuvant and veterinary vaccine adjuvant. The human vaccine adjuvant segment held the largest share of the market in 2023.

Vaccine Adjuvants Market Share Analysis by Geography

The geographic scope of the Vaccine Adjuvants market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America has dominated the market and Asia Pacific is anticipated to grow with the highest CAGR in the coming years. Rising infectious disease and pandemics contribute to accelerating vaccine adjuvant production in Asia Pacific, influencing market growth during 2022-2030. In India, there is high support from the National Institute of Health (NIH), which contributes to the production of vaccines. One such example is the adjuvant developed by NIH funding to enhance the efficacy of India's COVAXIN Alhydroxiquim-II vaccine. The adjuvant used in COVAXIN, named “Alhydroxiquim-II”, was discovered and tested in the laboratory by ViroVax LLC, by incorporating a small molecule attached to “Alhydrogel”, a substance commonly known as alum standing as the most common adjuvant used in the vaccines for people.

Vaccine Adjuvants Market Report Scope

Report Attribute Details
Market size in 2023 US$ 2.79 Billion
Market Size by 2031 US$ 7.96 Billion
Global CAGR (2023 - 2031) 14.0%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Adjuvant Class
  • Mineral Salt Adjuvant
  • Emulsion Adjuvant
  • Liposome Adjuvant
By Type
  • Human Vaccine Adjuvant
  • Veterinary Vaccine Adjuvant
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • SPI Pharma Inc
  • GSK Plc
  • CSL Ltd
  • Seppic SA
  • Hawaii Biotech Inc.
  • Dynavax Technologies Corp
  • InvivoGen SAS
  • Croda International Plc
  • Novavax Inc
  • Phibro Animal Health Corp
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

    Vaccine Adjuvants Market News and Recent Developments

    The vaccine adjuvants market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the vaccine adjuvants market are listed below:

    • SPI Pharma Inc and Q-Vant Biosciences Inc partnered to combines Q-Vant's leadership in sustainable saponin extraction technology with SPI's global reach and servicing expertise in the pharmaceutical industry. This includes investment in expanding Q-Vant’s proprietary 100% sustainable Q-SAP technology and an exclusive commercial agreement to accelerate the global adoption of their saponin adjuvants for veterinary and human vaccine formulations. (Source: SPI Pharma Inc, Press Release, October 2023)
    • Seppic launched MONTANIDE GEL P PR, an aqueous adjuvant based on a polymeric technology dedicated to avian injectable vaccines, meeting the need for innocuity in the avian market. In addition, MONTANIDE GEL P PR is particularly stable and can resist destabilising antigenic media frequently used in avian vaccines. (Source: Seppic, Press Release, May 2024)

    Vaccine Adjuvants Market Report Coverage and Deliverables

    The “Vaccine Adjuvants Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Vaccine adjuvants market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Vaccine adjuvants market trends, as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Vaccine adjuvants market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments3
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Vaccine Adjuvants market
    • Detailed company profiles
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    Adjuvant Class, Type, and Geography

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    Which region dominated the vaccine adjuvants market in 2023?

    North America has dominated the vaccine adjuvants market

    What are the driving factors impacting the vaccine adjuvants market?

    Advantageous and product approvals of veterinary vaccine adjuvants are the key driving factors behind the market development.

    What are the future trends of the vaccine adjuvants market?

    Technological advancements is likely to remain key trends in the market

    What would be the estimated value of the vaccine adjuvants market by 2031?

    The vaccine adjuvants market size is projected to reach US$ 7.96 billion by 2031.

    What is the expected CAGR of the vaccine adjuvants market?

    The market is expected to register a CAGR of 14.0% during 2023–2031

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • 3.1 Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • 3.2 Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • 3.3 Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • 3.4 Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Trends and growth analysis reports related to Vaccine Adjuvants Market


    -->